Dr. John Ryals co-founded Metabolon, Inc. in 2002 and serves as president and CEO. Metabolon is a pioneer and leader in the field of metabolomics and its use in precision medicine and human health. Prior to Metabolon, he was a co-founder, CEO and president of Paradigm Genetics, Inc., a publicly traded agricultural biotechnology company focused on industrializing the process of gene function discovery. Dr. Ryals has 30 years’ experience in the biotechnology industry, including senior research positions at Novartis and Ciba-Geigy. He currently serves on the board of directors at AgBiome, a provider of early-stage R&D for agriculture, and the advisory board of the College of Agriculture and Life Sciences at North Carolina State University. He earned a B.A. in biology and chemistry from the University of North Texas and M.S. and Ph.D. degrees in molecular biology from the University of Texas at Dallas.
Metabolomics: The Missing Link in Precision Medicine
Wednesday, 30 September 2015 at 14:00
Add to Calendar ▼2015-09-30 14:00:002015-09-30 15:00:00Europe/LondonMetabolomics: The Missing Link in Precision MedicineNGS, SCA, Mass Spec: The Road to Diagnostics in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Metabolon has developed a platform technology capitalizing on advances in mass spectrometry, proprietary software and database analysis to provide unprecedented insight into biochemical pathways. Along with information provided by whole genome or exome sequencing technologies, metabolite data provides ontology for determining genome wide associations. This insight is critical to determining penetrance of a gene determinant of interest and relating it to health status. Because metabolites are more closely linked to actionable information, metabolomics can provide clinicians with more insight to the patient’s health status. With or without genetic information, metabolomics will play a big role in the future of precision medicine.
Add to Calendar ▼2015-09-28 00:00:002015-09-30 00:00:00Europe/LondonNGS, SCA, Mass Spec: The Road to DiagnosticsNGS, SCA, Mass Spec: The Road to Diagnostics in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2015-09-30 14:00:002015-09-30 15:00:00Europe/LondonMetabolomics: The Missing Link in Precision MedicineNGS, SCA, Mass Spec: The Road to Diagnostics in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
